Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

Use of guideline-recommended therapies for heart failure in the Medicare population.

Publication ,  Journal Article
DiMartino, LD; Shea, AM; Hernandez, AF; Curtis, LH
Published in: Clin Cardiol
July 2010

BACKGROUND: Most information about the use of guideline-recommended therapies for heart failure reflects what occurred at discharge after an inpatient stay. HYPOTHESIS: Using a nationally representative, community-dwelling sample of elderly Medicare beneficiaries, we examined how the use of angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and beta-blockers has changed and factors associated with their use. METHODS: Using data from the Medicare Current Beneficiary Survey cost and use files matched with Medicare claims data, we identified beneficiaries for whom a diagnosis of heart failure was reported between January 1, 2000, and December 31, 2004. Data on medications prescribed during the year of cohort entry were based on patient self-report. We used multivariable logistic regression to explore relationships between the use of ACE inhibitors/ARBs and beta-blockers and patient demographic characteristics. RESULTS: From 2000 through 2004, the use of ARBs increased from 12% to 19%, and the use of beta-blockers increased from 30% to 41%. The use of ACE inhibitors remained constant at 45%. Beneficiaries who reported having prescription drug insurance coverage were 32% more likely than other beneficiaries to have filled a prescription for an ACE inhibitor or ARB and 26% more likely to have filled a prescription for a beta-blocker. CONCLUSIONS: Although the use of guideline-recommended therapies for heart failure has increased, it remains suboptimal.

Duke Scholars

Published In

Clin Cardiol

DOI

EISSN

1932-8737

Publication Date

July 2010

Volume

33

Issue

7

Start / End Page

400 / 405

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Risk Factors
  • Risk Assessment
  • Practice Patterns, Physicians'
  • Practice Guidelines as Topic
  • Medicare
  • Male
  • Logistic Models
  • Insurance, Pharmaceutical Services
 

Citation

APA
Chicago
ICMJE
MLA
NLM
DiMartino, L. D., Shea, A. M., Hernandez, A. F., & Curtis, L. H. (2010). Use of guideline-recommended therapies for heart failure in the Medicare population. Clin Cardiol, 33(7), 400–405. https://doi.org/10.1002/clc.20760
DiMartino, Lisa D., Alisa M. Shea, Adrian F. Hernandez, and Lesley H. Curtis. “Use of guideline-recommended therapies for heart failure in the Medicare population.Clin Cardiol 33, no. 7 (July 2010): 400–405. https://doi.org/10.1002/clc.20760.
DiMartino LD, Shea AM, Hernandez AF, Curtis LH. Use of guideline-recommended therapies for heart failure in the Medicare population. Clin Cardiol. 2010 Jul;33(7):400–5.
DiMartino, Lisa D., et al. “Use of guideline-recommended therapies for heart failure in the Medicare population.Clin Cardiol, vol. 33, no. 7, July 2010, pp. 400–05. Pubmed, doi:10.1002/clc.20760.
DiMartino LD, Shea AM, Hernandez AF, Curtis LH. Use of guideline-recommended therapies for heart failure in the Medicare population. Clin Cardiol. 2010 Jul;33(7):400–405.
Journal cover image

Published In

Clin Cardiol

DOI

EISSN

1932-8737

Publication Date

July 2010

Volume

33

Issue

7

Start / End Page

400 / 405

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Risk Factors
  • Risk Assessment
  • Practice Patterns, Physicians'
  • Practice Guidelines as Topic
  • Medicare
  • Male
  • Logistic Models
  • Insurance, Pharmaceutical Services